| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Coexpression | LIAN_NEUTROPHIL_GRANULE_CONSTITUENTS | 2.44e-05 | 25 | 8 | 2 | M1478 | |
| Coexpression | LIAN_NEUTROPHIL_GRANULE_CONSTITUENTS | 2.64e-05 | 26 | 8 | 2 | MM639 | |
| Coexpression | MORI_MATURE_B_LYMPHOCYTE_DN | 2.30e-04 | 76 | 8 | 2 | M15847 | |
| Coexpression | MORI_MATURE_B_LYMPHOCYTE_DN | 2.74e-04 | 83 | 8 | 2 | MM596 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Fam19a1_Tmem182|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.09e-04 | 124 | 8 | 2 | 690595d710b57b7cff8029a3bb06a8dd7e3c03c1 | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.22e-04 | 154 | 8 | 2 | 58072ce422d09f2de602580325eaac6c4ec6c136 | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells-Ciliated|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.22e-04 | 154 | 8 | 2 | 9ca71d440c4f87781e6525b8141e7d8d470b6a8e | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.26e-04 | 155 | 8 | 2 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.26e-04 | 155 | 8 | 2 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | PND07-28-samps-Myeloid-Macrophage-macrophage-B|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 3.47e-04 | 160 | 8 | 2 | 694bf1f1952bd8ab444819f533da24fa2b73f701 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.64e-04 | 164 | 8 | 2 | e4d4c59aebe5cacd4ecdb907facd044dc82a831d | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Proliferating-cycling_ventral_progenitors|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 3.92e-04 | 170 | 8 | 2 | 73601c873b177d5d134618d8e228c51381119f7d | |
| ToppCell | facs-Lung-EPCAM-18m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.24e-04 | 177 | 8 | 2 | 3cb96d7d56c9ff90f1f8a6caaf49e580e2524c7d | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-ventral_progenitors_and_neurons_2|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 4.34e-04 | 179 | 8 | 2 | d95367d689732ab2653e8d70d8d8e5eb15ae6eef | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.39e-04 | 180 | 8 | 2 | 023ec0b080c8a5cd0f36e83c6b17d4be3c01edb5 | |
| ToppCell | COVID-19-kidney-NK|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.44e-04 | 181 | 8 | 2 | 8906ee8a7a1616dfe8c3b5c73988416641213629 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.58e-04 | 184 | 8 | 2 | 3261d767d5e3d9e9fbac22ad73ca14e44beed89c | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.63e-04 | 185 | 8 | 2 | 53a5218c1e6eb12daccde3d6e02f337e2586d74c | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 4.68e-04 | 186 | 8 | 2 | bbb8edea8d8bdc1a469faec1563e40b1f62d7f3d | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.73e-04 | 187 | 8 | 2 | f20e7a1751694390f535ffb27b97e887220f8695 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_GGH|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.73e-04 | 187 | 8 | 2 | eb011a3d8a3025cebb0fba36d403be906305372c | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.73e-04 | 187 | 8 | 2 | f0c6e53035b00772377c4d5f761b4d11026b911a | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.83e-04 | 189 | 8 | 2 | 6d24414ac6bd4f03f7a5ad3a6eba51d549a7b112 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.83e-04 | 189 | 8 | 2 | b2542b6fcf7bc10d29158d42b03182a939ff135a | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.83e-04 | 189 | 8 | 2 | 287e59104687fe1665232c52993889f0f2c97f17 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.89e-04 | 190 | 8 | 2 | da58227565ad6a690828dd8554dd3670222f8582 | |
| ToppCell | droplet-Marrow-BM-1m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.99e-04 | 192 | 8 | 2 | 19b8675ed8a99bd3d08ad043e4ec9f006426c22f | |
| ToppCell | droplet-Thymus-nan-3m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.99e-04 | 192 | 8 | 2 | 041124dd5c24c1eb188d2560ba606422c0b215c5 | |
| ToppCell | droplet-Marrow-BM-1m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.99e-04 | 192 | 8 | 2 | ced2fdbcb181ac250ff50cd4d5d886e568924203 | |
| ToppCell | droplet-Thymus-nan-3m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.99e-04 | 192 | 8 | 2 | d9e61b2722aa81e4f6e11865a04f2f1e75b794ab | |
| ToppCell | droplet-Lung-1m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.09e-04 | 194 | 8 | 2 | d16ab5f0cfe73afe6c551fd3123d14784a082f56 | |
| ToppCell | droplet-Lung-LUNG-1m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.09e-04 | 194 | 8 | 2 | 621e0e8fe77ff0be83ea9287ce46e97c47e2b3b9 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.20e-04 | 196 | 8 | 2 | f068ce40bf35021baf1468ae9ce30a92162eb14d | |
| ToppCell | LPS_IL1RA_TNF-Hematopoietic_Myeloid-Dendritic_cells-pDC|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.25e-04 | 197 | 8 | 2 | 8fa38fb95e285f9cc756ec4f32009be4ede09d3c | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.25e-04 | 197 | 8 | 2 | 7b12f9d4ad1e84df58e86591a491c84d4f36eac5 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-oligodendrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.30e-04 | 198 | 8 | 2 | 97ae237f955fd5fbd01d06aafe89ef9e6f777a9a | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial-Ciliated|LPS_only / Treatment groups by lineage, cell group, cell type | 5.30e-04 | 198 | 8 | 2 | 6d90b541fde357fbb40f8f7d4e8628a48b679718 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.30e-04 | 198 | 8 | 2 | fab3135f03cf23a9f04f0eed543a9dc181f39f5f | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Macroglial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.30e-04 | 198 | 8 | 2 | fef9a4c96450078527b94d25e681410e4ea01b13 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Macroglial-oligodendrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.30e-04 | 198 | 8 | 2 | a183afe4c2034323f77abfa080f359d67da35e8f | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial|LPS_only / Treatment groups by lineage, cell group, cell type | 5.30e-04 | 198 | 8 | 2 | e035380578c01b0243bfef29ca9b50cc17cce771 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Macroglial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.30e-04 | 198 | 8 | 2 | 27f0654fb0857e93f030e1a4b1c307b31576bbcd | |
| ToppCell | LPS_only-Epithelial_airway|LPS_only / Treatment groups by lineage, cell group, cell type | 5.30e-04 | 198 | 8 | 2 | ba090210392e001a3f7bdf09371b3f0e0c8c7ef3 | |
| ToppCell | LPS_IL1RA-Hematopoietic_Myeloid-Dendritic_cells-mDC|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.30e-04 | 198 | 8 | 2 | e8002972410e4803d85263ba2642e6855cef83e9 | |
| ToppCell | LPS_IL1RA-Hematopoietic_Myeloid-Dendritic_cells|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.30e-04 | 198 | 8 | 2 | ba3b97bb3e1533df758e845bde7d82eb1525b057 | |
| ToppCell | LPS_anti-TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.36e-04 | 199 | 8 | 2 | 15f7814b7074170eee7ccacaa670b1d128fc68bb | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Macroglial-oligodendrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.36e-04 | 199 | 8 | 2 | 67d8c7e5356f5d409d4f98e8338cf6c499fd7aee | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Macroglial-oligodendrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.41e-04 | 200 | 8 | 2 | e5b4821fff40566c4a7dc3f74a14e27eb06b165d | |
| ToppCell | LPS_IL1RA-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.41e-04 | 200 | 8 | 2 | 4992dbf0514d674017315dbd20d91dfec0c608e9 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.41e-04 | 200 | 8 | 2 | 96701a4d57753f5ec0dd5c7550054bbcc946bc5f | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Macroglial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.41e-04 | 200 | 8 | 2 | 56f1f007ba8c9188a4b10e52744f1e50dc0f155a | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Macroglial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.41e-04 | 200 | 8 | 2 | 0e85c90719d9ec51a566e230c9dd2909d8df1f52 | |
| Drug | alendronate | 4.26e-04 | 90 | 8 | 2 | CID000002088 | |
| Drug | troglitazone; Down 200; 10uM; PC3; HT_HG-U133A | 1.86e-03 | 189 | 8 | 2 | 1232_DN | |
| Drug | LY 294002; Down 200; 10uM; PC3; HT_HG-U133A | 1.90e-03 | 191 | 8 | 2 | 4451_DN | |
| Drug | pioglitazone HCl; Down 200; 10uM; PC3; HT_HG-U133A | 1.92e-03 | 192 | 8 | 2 | 5930_DN | |
| Drug | LY 294002; Down 200; 10uM; PC3; HT_HG-U133A | 1.94e-03 | 193 | 8 | 2 | 4460_DN | |
| Drug | L(-)-vesamicol hydrochloride [112709-59-8]; Up 200; 13.6uM; PC3; HT_HG-U133A | 1.96e-03 | 194 | 8 | 2 | 5056_UP | |
| Drug | CP-690334-01 [459212-38-5]; Down 200; 1uM; PC3; HT_HG-U133A | 1.96e-03 | 194 | 8 | 2 | 3826_DN | |
| Drug | Diprophylline [479-18-5]; Up 200; 15.8uM; PC3; HT_HG-U133A | 2.00e-03 | 196 | 8 | 2 | 5063_UP | |
| Drug | Thiamphenicol [15318-45-3]; Up 200; 11.2uM; HL60; HT_HG-U133A | 2.00e-03 | 196 | 8 | 2 | 1867_UP | |
| Drug | Etilefrine hydrochloride [534-87-2]; Up 200; 18.4uM; MCF7; HT_HG-U133A | 2.00e-03 | 196 | 8 | 2 | 4415_UP | |
| Drug | 0173570-0000 [211245-44-2]; Down 200; 1uM; PC3; HT_HG-U133A | 2.00e-03 | 196 | 8 | 2 | 7391_DN | |
| Drug | Chloroquine diphosphate [50-63-5]; Up 200; 7.8uM; PC3; HT_HG-U133A | 2.00e-03 | 196 | 8 | 2 | 7251_UP | |
| Drug | N6,2-O-dibutyryladenosine 3,5-cyclic monophosphate sodium salt; Up 200; 2uM; MCF7; HT_HG-U133A_EA | 2.02e-03 | 197 | 8 | 2 | 959_UP | |
| Drug | ICI182,780; Up 200; 1uM; PC3; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 7495_UP | |
| Drug | Methylatropine nitrate [52-88-0]; Up 200; 11uM; PC3; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 7253_UP | |
| Drug | Ketorolac tromethamine [74103-07-4]; Down 200; 10.6uM; PC3; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 7286_DN | |
| Drug | Methylhydantoin-5-(D) [55147-68-7]; Up 200; 35uM; MCF7; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 4113_UP | |
| Drug | Amiloride hydrochloride dihydrate [17440-83-4]; Up 200; 13.2uM; PC3; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 3990_UP | |
| Drug | Dyclonine hydrochloride [536-43-6]; Up 200; 12.2uM; PC3; HT_HG-U133A | 2.04e-03 | 198 | 8 | 2 | 7261_UP | |
| Drug | Mianserine hydrochloride [21535-47-7]; Down 200; 13.2uM; PC3; HT_HG-U133A | 2.04e-03 | 198 | 8 | 2 | 2068_DN | |
| Drug | Meclofenamic acid sodium salt monohydrate [6385-02-0]; Up 200; 11.8uM; PC3; HT_HG-U133A | 2.04e-03 | 198 | 8 | 2 | 7280_UP | |
| Drug | 0225151-0000 [351320-15-5]; Down 200; 10uM; PC3; HT_HG-U133A | 2.04e-03 | 198 | 8 | 2 | 6426_DN | |
| Drug | Levonordefrin [829-74-3]; Up 200; 21.8uM; MCF7; HT_HG-U133A | 2.04e-03 | 198 | 8 | 2 | 3450_UP | |
| Disease | Liver Cirrhosis, Experimental | 1.73e-02 | 774 | 8 | 2 | C0023893 | |
| Disease | systemic lupus erythematosus | 1.84e-02 | 799 | 8 | 2 | MONDO_0007915 | |
| Disease | serum metabolite measurement | 2.52e-02 | 945 | 8 | 2 | EFO_0005653 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MENFKEHHWKKFFTS | 1461 | Q9P1Z9 | |
| EHHWKKFFTSVKEIR | 1466 | Q9P1Z9 | |
| HSEVEKAFKKAFKVW | 131 | P45452 | |
| TTVKHVLKHSWFFFA | 981 | Q96BY6 | |
| IWHTSIVVHKDEFFF | 36 | Q6ICB0 | |
| EVHWHEAHKFLKVEF | 801 | Q9NTJ4 | |
| TKKIKVGEFFSHVVW | 76 | Q9NTJ5 | |
| HWSHYQVRDKFKKFD | 511 | Q6AI14 | |
| FEVKVFKEKHHSWFI | 61 | Q5TBB1 |